Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A for male androgenetic alopecia
IRCT20231231060578N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of botulinum toxin type A in androgenetic alopecia (AGA), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Hair count statistics and Objective evaluation score of head photographs. Started Jan 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20231231060578N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231231060578N1.